Search results
SYS r022114 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20130617140548.5 100 $a 20030704a2003 m y0sloc0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain $f H. Ando ... [et al.] 463 -1
$1 001 sllk_un_cat*sg000136_2003_003_002 $1 011 $a 1210-0668 $a 1336-0329 $1 011 $a 1210-0668 $a 1336-0329 $1 200 1 $a Endocrine regulations $v Vol. 37, no. 2 (2003), s. 84 $1 210 $a Bratislava $c Slovak Academic Press 541 1-
$a Blokáda receptora angiotenzínu II AT1 zmenšuje zápalový proces mozgovej artérie v línii potkanov, (geneticky) vnímavých na stres 606 1-
$3 sllk_un_auth*d000806 $a ACE inhibítory $x analýza $x použitie diagnostické $x použitie terapeutické $9 . $2 mesh 606 1-
$3 sllk_un_auth*d020765 $a choroby intrakraniálne arteriálne $x klasifikácia $x farmakoterapia $x mikrobiológia $9 . $2 mesh 606 1-
$a vaskulitída centrálneho nervového systému $x klasifikácia $x farmakoterapia $x etiológia $2 mesh $3 sllk_un_auth*d020293 $9 . 606 2-
$a hypertenzia intrakraniálna $x komplikácie $x etiológia $2 mesh $3 sllk_un_auth*d019586 $9 . 606 2-
$3 sllk_un_auth*d013312 $a stres fyziologický $9 . $2 mesh 606 2-
$a potkany inbredné SHR $x genetika $x mikrobiológia $2 mesh $3 sllk_un_auth*d011918 $9 . 608 $3 sllk_un_auth*d016416 $a abstrakt z kongresu $2 mesh 675 $a 616.133-002-07-08-001.9:159.91:061.3 $v 2. $z slo 701 -1
$a Ando $b H. $3 sllk_un_auth*p0030674 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$3 sllk_un_auth*p0053111 $a Ježová $b Marta $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA $4 070 702 -1
$a Zhou $b J. $3 sllk_un_auth*p0030677 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$a Saavedra $b J.M. $3 sllk_un_auth*p0030678 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 711 12
$3 sllk_un_auth*k0001867 $a Symposium on catecholamines and other neurotransmitters in stress $d 8. $e Smolenice, Slovensko $f 2003 801 -0
$a SK $b BA006 $c 20030704 $g AACR2 SYS r022410 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20130617135937.2 100 $a 20030721a2003 m y0sloc0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Angiotensin II, an important stress hormone: multiple regulatory sites and therapeutic opportunities $f J.M. Saavedra ... [et al.] 463 -1
$1 001 sllk_un_cat*sg000136_2003_003_002 $1 011 $a 1210-0668 $a 1336-0329 $1 011 $a 1210-0668 $a 1336-0329 $1 200 1 $a Endocrine regulations $v Vol. 37, no. 2 (2003), s. 125 $1 210 $a Bratislava $c Slovak Academic Press 541 1-
$a Angiotenzín II, dôležitý stresový hormón: mnohopočetné kontrolné miesta a možnosti liečby 606 1-
$a angiotenzín II $x analógy a deriváty $x analýza $x biosyntéza $2 mesh $3 sllk_un_auth*d000804 $9 . 606 1-
$3 sllk_un_auth*d013312 $a stres fyziologický $x etiológia $x genetika $9 . $2 mesh 606 1-
$3 sllk_un_auth*d000806 $a ACE inhibítory $x farmakokinetika $x metabolizmus $9 . $2 mesh 606 2-
$a systém hypotalamo-hypofýzový $x účinky liekov $x metabolizmus $2 mesh $3 sllk_un_auth*d007030 $9 . 606 2-
$a systém hypofýzo-nadobličkový $x účinky liekov $x metabolizmus $2 mesh $3 sllk_un_auth*d010913 $9 . 606 2-
$a prevencia primárna $x metódy $x trendy $2 mesh $3 sllk_un_auth*d011322 $9 . 608 $3 sllk_un_auth*d016416 $a abstrakt z kongresu $2 mesh 675 $a 159.91:612.4:577.175.5:615.225.2:061.3 $v 2. $z slo 701 -1
$a Saavedra $b J.M. $3 sllk_un_auth*p0030678 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$a Ando $b H. $3 sllk_un_auth*p0030674 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$a Armando $b I. $3 sllk_un_auth*p0030679 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$a Baiardi $b G. $3 sllk_un_auth*p0030682 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$a Bregonzio $b C. $3 sllk_un_auth*p0030681 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 702 -1
$3 sllk_un_auth*p0053111 $a Ježová $b Marta $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA $4 070 702 -1
$a Zhou $b J. $3 sllk_un_auth*p0030677 $4 070 $p Section on pharmacology, Division of intramural research programs, National institute of mental health, National institutes of health, Department of health and human services, Bethesda, Maryland, USA 711 12
$3 sllk_un_auth*k0001867 $a Symposium on catecholamines and other neurotransmitters in stress $d 8. $e Smolenice, Slovensko $f 2003 801 -0
$a SK $b BA006 $c 20030721 $g AACR2 SYS r022440 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20130617140354.2 100 $a 20030722a2003 m y0sloc0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a AT1 receptor blockade down-regulates stress-linked heat shock proteins in brain microvessels from spontaneously hypertensive rats $f J. Zhou ... [et al.] 463 -1
$1 001 sllk_un_cat*sg000136_2003_003_002 $1 011 $a 1210-0668 $a 1336-0329 $1 011 $a 1210-0668 $a 1336-0329 $1 200 1 $a Endocrine regulations $v Vol. 37, no. 2 (2003), s. 134 $1 210 $a Bratislava $c Slovak Academic Press 541 1-
$a AT1 negatívna receptorová blokáda proteínov teplotného šoku, vyvolaných stresom v mozgových mikrocievach u spontánne hypertenzívnych potkanov 606 1-
$3 sllk_un_auth*d015536 $a down-regulácia $x genetika $x imunológia $9 . $2 mesh 606 1-
$a angiotenzín II $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d000804 $9 . 606 1-
$3 sllk_un_auth*d000317 $a antagonisty alfa-adrenergických receptorov $x použitie diagnostické $9 . $2 mesh 606 2-
$a proteíny teplotného šoku $x účinky nežiaduce $x použitie diagnostické $2 mesh $3 sllk_un_auth*d006360 $9 . 606 2-
$3 sllk_un_auth*d013312 $a stres fyziologický $x klasifikácia $x komplikácie $x etiológia $9 . $2 mesh 606 2-
$a mikrocirkulácia $x imunológia $x patofyziológia $2 mesh $3 sllk_un_auth*d008833 $9 . 608 $3 sllk_un_auth*d016416 $a abstrakt z kongresu $2 mesh 675 $a 615.217.2:159.91:061.3 $v 2. $z slo 701 -1
$a Zhou $b J. $3 sllk_un_auth*p0030677 $4 070 $p Section of pharmacology, National institute of mental health, National institutes of health, Department of healt and human services, Bethesda, Maryland, USA 702 -1
$3 sllk_un_auth*p0025440 $a Ježová $b Daniela $f 1949- $p Section of pharmacology, National institute of mental health, National institutes of health, Department of healt and human services, Bethesda, Maryland, USA $4 070 702 -1
$a Ando $b H. $3 sllk_un_auth*p0030674 $4 070 $p Section of pharmacology, National institute of mental health, National institutes of health, Department of healt and human services, Bethesda, Maryland, USA 702 -1
$a Saavedra $b J.M. $3 sllk_un_auth*p0030678 $4 070 $p Section of pharmacology, National institute of mental health, National institutes of health, Department of healt and human services, Bethesda, Maryland, USA 711 12
$3 sllk_un_auth*k0001867 $a Symposium on catecholamines and other neurotransmitters in stress $d 8. $e Smolenice, Slovensko $f 2003 801 -0
$a SK $b BA006 $c 20030722 $g AACR2 SYS 0080966 LBL 00000naa^^22^^^^^^^^450 005 20161222105510.9 100 $a 20120926a2006 m y0sloy0103 ba 101 0-
$a eng 102 $a NL 200 1-
$a Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR-gamma $f Zorad S. ... [et al.] 303 $a Popis urobený z citácie 463 -1
$1 200 1 $a European journal of pharmacology $v Vol. 552 (2006), s. 112-122 701 -1
$3 sllk_un_auth*p0033718 $a Zórad $b Štefan $p Ústav experimentálnej endokrinológie SAV, Bratislava $4 070 701 -1
$3 sllk_un_auth*0006396 $a Dou $b JT $p Department of Endocrinology, PLA General Hospital, Beijing, China $4 070 701 -1
$3 sllk_un_auth*p0011534 $a Benický $b Jozef $p Institute of experimental endocrinology, Center of excellence, Slovak academy of sciences, Bratislava $4 070 701 -1
$3 sllk_un_auth*0026883 $a Hutanu $b D. $4 070 701 -1
$3 sllk_un_auth*p0057045 $a Tybitanclová $b Katarína $p Department of Biochemical Technology, Faculty of Chemical Technology, Slovak Technical University, Radlinského 9, SK-81237 Bratislava, Slovakia $4 070 701 -1
$3 sllk_un_auth*p0030677 $a Zhou $b J. $4 070 701 -1
$3 sllk_un_auth*p0030678 $a Saavedra $b J.M. $4 070 801 -0
$a SK $b BA006 $c 20120926 $g AACR2